EW News and Press, Edwards Lifesciences Corporation From 04/09/20

IRVINE, Calif. , April 9, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended March 31, 2020 after the ...

New York City, NY: April 06, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Central Line Market in Global Industry: 2020 Research and New Innovations in Medical Devices Sector. The prime objective of the report is to offer updates and inform...

New York City, NY: April 06, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Central Venous Catheters Market in Global Industry: 2020 Research and New Innovations in Medical Devices Sector. The prime objective of the report is to offer update...

The coronavirus outbreak pushed stocks into a bear market in March, but these sharp declines do offer us opportunities to buy shares of otherwise healthy companies that may lift our portfolios in the long term. Though 2020 looks foggy for everyone at the moment, the following two stocks had the ...

Introduction This article is a follow-up to a series of articles I recently wrote about how to avoid losses and profit from sentiment cycles. If you are already familiar with the strategy, feel free to skip down the "Opportunity Risk/Reward" section and read from there. If you are new to the...

IRVINE, Calif. , March 29, 2020 /PRNewswire/ --   Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced 2-year results of the randomized PARTNER 3 trial comparing treatm...

As the economy continues to struggle under the weight of the COVID-19 pandemic, investors have seen stock prices plummet. While some healthcare stocks directly involved in combating the virus experienced nice gains, many otherwise healthy companies saw their share prices erode over the past mont...

IRVINE, Calif. , March 28, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it will temporarily pause new enrollments in its active pivotal clinical...

This article is first in a series that provides an ongoing analysis of the changes made to Wedgewood Partners’ 13F stock portfolio on a quarterly basis. It is based on David Rolfe’s regulatory 13F Form filed on 02/14/2020. The 13F portfolio value decreased ~13%, from $1.13B to ...

Short Take Silk Road Medical ( SILK ) went public on April 4, 2019 and recently reported calendar year 2019 financial results. The firm produces carotid artery medical devices to protect patients from stroke. SILK expects strong growth in 2020, but that may be attenuated by unforeseen ef...